Literature DB >> 23740459

Vernal keratoconjunctivitis: atopy and autoimmunity.

A M Zicari1, M Nebbioso, V Lollobrigida, F Bardanzellu, C Celani, F Occasi, A Cesoni Marcelli, M Duse.   

Abstract

BACKGROUND: Vernal Keratoconjunctivitis (VKC) is a rare chronic ocular inflammatory disease and it mainly affects boys in the first decade of life. Although it is a self-limiting disease, patients may present many phases characterized by an exacerbation of inflammatory symptoms with a consequent decline of the quality of life.
PURPOSE: define the clinical and immunological profile of patients affected by VKC and investigate their familiar history of autoimmune disorders and their autoimmunity pattern. PATIENTS AND METHODS: 28 children were enrolled (20 males, 71%) aged between 4 and 14 years of life affected by VKC. Family history of allergic and immunological diseases was collected for each patient. In particular, it was asked whether some components of their families were affected by Hashimoto's thyroiditis, type I diabetes, psoriasis or rheumatoid arthritis and Systemic Lupus Erythematosus (SLE). All VKC children underwent a serological evaluation of anti-nuclear antibodies (ANA).
RESULTS: A family history of immunological disorders was found in 46% of patients, 28% of Hashimoto's thyroiditis, 14% of type I diabetes, 14% of psoriasis, and 1 of Systemic Lupus Erythematosus. Furthermore, 35% of patients was ANA positive and they corresponded to patients with a higher ocular score and with the most important clinical symptoms.
CONCLUSIONS: the detection of ANA positivity and of a familiar history of autoimmune disorders in a high percentage of children with VKC may help us to better understand the association of this ocular inflammatory disease with systemic autoimmune disorders and atopic condition.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23740459

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  9 in total

Review 1.  An Update on the Therapeutic Approach to Vernal Keratoconjunctivitis.

Authors:  Susanna Esposito; Giulia Fior; Alessandro Mori; Silvia Osnaghi; Daniele Ghiglioni
Journal:  Paediatr Drugs       Date:  2016-10       Impact factor: 3.022

2.  Increased incidence of thyroid dysfunction and autoimmunity in patients with vernal keratoconjunctivitis.

Authors:  Stefano Stagi; Neri Pucci; Laura Di Grande; Cinzia de Libero; Roberto Caputo; Stefano Pantano; Ivan Mattei; Francesca Mori; Maurizio de Martino; Elio Novembre
Journal:  Int J Endocrinol       Date:  2014-07-20       Impact factor: 3.257

3.  Management of vernal keratoconjunctivitis.

Authors:  Andrea Leonardi
Journal:  Ophthalmol Ther       Date:  2013-09-07

Review 4.  An Update on Anti-IgE Therapy in Pediatric Respiratory Diseases.

Authors:  Amelia Licari; Riccardo Castagnoli; Elisa Panfili; Alessia Marseglia; Ilaria Brambilla; Gian Luigi Marseglia
Journal:  Curr Respir Med Rev       Date:  2017-03

5.  Risk of allergic conjunctivitis in patients with type 1 diabetes mellitus: a population-based retrospective cohort study.

Authors:  Yin-Huei Chen; Cheng-Li Lin; Da-Tian Bau; Yi-Chih Hung
Journal:  BMJ Open       Date:  2017-06-19       Impact factor: 2.692

6.  The role of human immunodeficiency virus in the pathogenesis of vernal keratoconjunctivitis-like disease in adults: A demographic and epidemiological study.

Authors:  Anine Kritzinger; Anthony G Zaborowski; Wilbert Sibanda; Linda Visser
Journal:  Indian J Ophthalmol       Date:  2020-08       Impact factor: 1.848

Review 7.  Vernal keratoconjunctivitis: state of art and update on treatment.

Authors:  Giulia Brindisi; Bianca Cinicola; Caterina Anania; Giovanna De Castro; Marcella Nebbioso; Michele Miraglia Del Giudice; Amelia Licari; Carlo Caffarelli; Maria De Filippo; Fabio Cardinale; Marzia Duse; Anna Maria Zicari
Journal:  Acta Biomed       Date:  2021-11-29

8.  Prevalence and associated factors of vernal keratoconjunctivitis among children in Gondar city, Northwest Ethiopia.

Authors:  Dereje Hayilu; Kbrom Legesse; Natinael Lakachew; Mulusew Asferaw
Journal:  BMC Ophthalmol       Date:  2016-09-29       Impact factor: 2.209

9.  Vascular Endothelial Growth Factor (VEGF) Serological and Lacrimal Signaling in Patients Affected by Vernal Keratoconjunctivitis (VKC).

Authors:  Marcella Nebbioso; Andrea Iannaccone; Marzia Duse; Michele Aventaggiato; Alice Bruscolini; Anna Maria Zicari
Journal:  J Ophthalmol       Date:  2018-09-16       Impact factor: 1.909

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.